Liver Cancer Market
List of reports from Liver Cancer
Displaying 1 to 13 (of 13 records)
| Pages: « Last 1 |
|
Liver Cancer - Pipeline Review, H1 2013
Feb 2013 | By - Global Markets Direct
Liver Cancer - Pipeline Review, H1 2013 Summary Global Markets Directs, 'Liver Cancer - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Liver Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
|
$2000 |
|
Metastatic Liver Cancer - Pipeline Review, H1 2013
Feb 2013 | By - Global Markets Direct
Metastatic Liver Cancer Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Metastatic Liver Cancer Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Liver Cancer, complete with latest updates, and special features on late-stage and...
|
$2000 |
|
Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail
Dec 2012 | By - GBI Research
Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail
Summary
Leading business intelligence provider, GBI Research, has released its latest research report, entitled: “Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted...
|
$3500 |
|
Liver Cancer Global Clinical Trials Review, H2, 2012
Dec 2012 | By - GlobalData
Liver Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData's clinical trial report, Liver Cancer Global Clinical Trials Review, H2, 2012" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their...
|
$2500 |
|
Liver Cancer - Pipeline Review, H2 2012
Sep 2012 | By - Global Markets Direct
Liver Cancer Pipeline Review, H2 2012
Global Markets Directs, 'Liver Cancer Pipeline Review, Global Markets Directs, 'Liver Cancer Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Liver Cancer, complete with latest updates, and special features on late-stage and...
|
$2500 |
|
Chinese Markets for Liver Cancer Treatment Drugs
Aug 2012 | By - Asia Market Information & Development Company
China's demand for liver cancer treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data...
|
$4000 |
|
Liver Cancer Partnering 2007-2012
Jun 2012 | By - Current Partnering
The Liver Cancer Partnering 2007-2012 provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of liver cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors liver...
|
$995 |
|
Liver Cancer Partnering Partnering 2007-2012
Mar 2012 | By - Current Partnering
This is an on demand report, it will take 20 to 25 working days to complete
The ‘Liver Cancer Partnering 2007-2012’ provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides an analysis of liver cancer partnering deals. The majority of deals are discovery or...
|
$995 |
|
Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012
Jan 2012 | By - GlobalData
GlobalData's clinical trial report, Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial...
|
$1000 |
|
Liver Cancer Global Clinical Trials Review, H2, 2011
Nov 2011 | By - GlobalData
Liver Cancer Global Clinical Trials Review, H2, 2011
GlobalData's clinical trial report, Liver Cancer Global Clinical Trials Review, H2, 2011" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as...
|
$1000 |
|
Liver Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010 | By - GlobalData
GlobalData's clinical trial report, “ Liver Cancer Global Clinical Trials Review, Q4, 2010"" provides data on the Liver Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world,...
|
$1000 |
|
Liver Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 | By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, “Liver Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global liver cancer market. The report identifies the key trends shaping and driving the global Liver cancer market. The report also provides insights on the...
|
$2000 |
|
Metastatic Liver Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010 | By - GlobalData
GlobalData's clinical trial report, “Metastatic Liver Cancer Global Clinical Trials Review, Q4, 2010"" provides data on the Metastatic Liver Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Metastatic Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial...
|
$1000 |
Displaying 1 to 13 (of 13 records)
| Pages: « Last 1 |
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Email: sales@researchmoz.us
